Literature DB >> 12082635

BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).

Elizabeth A Williamson1, Farnaz Dadmanesh, H Phillip Koeffler.   

Abstract

The p27(Kip1) is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of p27(Kip1) and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27(Kip1). This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position -615 to -511 of the p27(Kip1) promoter. These results suggest that the transcriptional regulation of p27(Kip1) by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082635     DOI: 10.1038/sj.onc.1205461

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  DNA damage response mediated through BRCA1.

Authors:  Eun Ryoung Jang; Jong-Soo Lee
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

2.  Mitogenic regulation of p27(Kip1) gene is mediated by AP-1 transcription factors.

Authors:  Ekta Khattar; Vijay Kumar
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

3.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

4.  BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4.

Authors:  Dan Li; Nan Kang; Junfang Ji; Qimin Zhan
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

Review 5.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

6.  Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.

Authors:  Irene Guendel; Lawrence Carpio; Caitlin Pedati; Arnold Schwartz; Christine Teal; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

7.  Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.

Authors:  Anne Catharina Dressler; Gernot Hudelist; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Margit Rosner; Markus Hengstschläger; Christian F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-21       Impact factor: 4.553

8.  BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.

Authors:  Annie Moisan; Chantal Larochelle; Benoît Guillemette; Luc Gaudreau
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 9.  P21 and p27: roles in carcinogenesis and drug resistance.

Authors:  Abde M Abukhdeir; Ben Ho Park
Journal:  Expert Rev Mol Med       Date:  2008-07-01       Impact factor: 5.600

10.  Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans.

Authors:  Angela Burk-Herrick; Mark Scally; Heather Amrine-Madsen; Michael J Stanhope; Mark S Springer
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.